Zobrazeno 1 - 10
of 34
pro vyhledávání: '"M, Onetto"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
C. Martinoli, M. Onetto, R. Lionetto, L. Fazzuoli, G. Rollandi, S. Saccomanno, A. Allegretto, V. Pugliese, M. Marugo, Michela Paganuzzi
Publikováno v:
Oncology. 50:77-80
In this phase II study, we treated 7 patients, all males, with stage III or IV pancreatic cancer with goserelin (an LH-RH analogue). Goserelin was administered at a dose of 3.6 mg every 4 weeks. The tumour response was assessed by measuring lesions w
Publikováno v:
Anticancer research. 14(3B)
It has been suggested that bile CEA levels could represent a sensitive index for the detection of occult liver metastases in colorectal cancer (CRC) patients. We measured serum and gallbladder bile CEA concentrations in a control group, in a group of
Autor:
E. Bombardieri, E. Seregni, A. Bogni, S. Ardit, S. Belloli, A. Busetto, B. Caniello, M. Castelli, A. Cianetti, M. Correale, G. De Angelis, G.M. Gandolfo, M. Gion, V. Macchia, R. Mione, F. Navaglia, M. Onetto, M. Paganuzzi, F. Pecchio, M. Plebani, M. Rapellino, G. Ruggeri, P. Vannini, G. Vitelli, A. Zamperlin
Publikováno v:
The International journal of biological markers. 9(2)
Recently, a new immunometric assay (Cyfra 21–1) was developed to measure serum concentrations of a soluble fragment of cytokeratin subunit 19. With this method, supplied by Boehringer Mannheim (EIA Test Cyfra 21–1), an Italian multicenter trial w
Autor:
A, Allegretti, R, Lionetto, S, Saccomanno, M, Paganuzzi, M, Onetto, C, Martinoli, G, Rollandi, M, Marugo, L, Fazzuoli, V, Pugliese
Publikováno v:
Oncology. 50(2)
In this phase II study, we treated 7 patients, all males, with stage III or IV pancreatic cancer with goserelin (an LH-RH analogue). Goserelin was administered at a dose of 3.6 mg every 4 weeks. The tumour response was assessed by measuring lesions w
Autor:
L, Repetto, M, Onetto, G, Gardin, B, Costanzi, S, Giudici, E, Vitiello, L, Merlini, C, Naso, C, Zannini, M, Paganuzzi
Publikováno v:
Cancer detection and prevention. 17(3)
With the aim of investigating the clinical usefulness of CEA, CA 15-3, and MCA serum levels, we studied 143 women whose breast cancer was submitted to serial tumor marker determinations: 79 women had stage I-II tumors and were undergoing follow-up af
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
The Journal of nuclear medicine and allied sciences. 34
Autor:
M, Bruzzone, M, Onetto, E, Campora, S, Chiara, C, Oliva, T, Guido, L, Merlini, S, Parodi, G, Bentivoglio, W, Ventrella
Publikováno v:
Anticancer research. 10(5A)
In 100 ovarian cancer patients serum CA-125 was monitored during treatment and follow-up to verify the prognostic value of its pre-surgery marker level and the usefulness of the test for disease monitoring. A low pre-operative CA-125 was not associat